Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-06-004010
Filing Date
2006-03-31
Accepted
2006-03-31 15:30:47
Documents
7
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y19213e10vk.htm 10-K 885670
2 EX-10.38: COLLABORATION AND LICENSE AGREEMENT y19213exv10w38.txt EX-10.38 186531
3 EX-10.39: EXCLUSIVE LICENSE AGREEMENT y19213exv10w39.txt EX-10.39 2589
4 EX-23.1: CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM y19213exv23w1.txt EX-23.1 1096
5 EX-31.1: CERTIFICATION y19213exv31w1.txt EX-31.1 3552
6 EX-31.2: CERTIFICATION y19213exv31w2.txt EX-31.2 3615
7 EX-32.1: CERTIFICATION y19213exv32w1.txt EX-32.1 2162
  Complete submission text file 0000950123-06-004010.txt   1086448
Mailing Address
Business Address 100 PHILIPS PARKWAY MONTVALE NJ 07645 2018027100
MEMORY PHARMACEUTICALS CORP (Filer) CIK: 0001062216 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 000-50642 | Film No.: 06728557
SIC: 2834 Pharmaceutical Preparations